Drug intelligence / Profile preview

Little Coughs

Development stage: Unknown
Lead developer: Paedpharm
Administration: Oral

Overview

Little Coughs is a pediatric cough syrup range formulated with natural ivy leaf extract (Hedera helix). It is designed to provide temporary relief from coughs and chesty congestion by acting as an expectorant to help break down mucus and clear the respiratory tract. The product is available in Original and Raspberry flavors, with the Raspberry version containing a higher concentration of the extract (210mg vs 102mg of dry leaf equivalent per 5mL). Marketed in Australia by Care Pharmaceuticals (a subsidiary of Prestige Consumer Healthcare), Little Coughs is part of a broader pediatric healthcare line. It is generally recommended for children over 2 years of age, with medical consultation advised for younger patients.

Brand names: Little Coughs
Other names: Hedera helix extractIvy leaf extract

Targets

ADRB2 (β2)

Beyond the preview

Go deeper on Little Coughs.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Little Coughs.

Explore the full profile